February 2022 COVID-19 VACCINATION AND RHEUMATIC DISEASEFeaturing: Eric M. Ruderman, MD
Episode SummaryIn this Better Edge podcast, Eric M. Ruderman, MD, associate chief and professor of Medicine in the Division of Rheumatology at Northwestern Medicine, discusses rheumatic disease activity following COVID-19 vaccination. He explores whether immunosuppressive medications affect vaccine effectiveness and any contraindications to COVID-19 vaccination for patients with rheumatic disease. Dr. Ruderman also talks about timing and use considerations for immunomodulatory therapy in relation to COVID-19 vaccination and other important considerations for physicians and advanced care providers caring for patients with rheumatic disease in the era of COVID-19.
|
Eric M. Ruderman, MD, is associate chief and professor of Medicine in the Division of Rheumatology at Northwestern Medicine.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|